Skip to main content

Curis Inc

CRIS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001108205

No open-market purchases or sales by Curis Inc insiders were filed in the last 90 days; 37 institutions reported holding it in 13F filings for Q2 2026, worth $7.96M in total; Maverick Capital is the only superinvestor holding it.

Q3 2024 vs. Q2 2024

How the institutions holding Curis Inc changed between Q2 2024 and Q3 2024.

All holders in Q3 2024All holders in Q2 2024

13F holders of CRIS: Q2 2024 compared with Q3 2024
MeasureQ2 2024Of which not filed for Q3 2024Q3 2024Change
Holders34132−1
Shares2.30M67.7K2.01M−226.4K (−10.1%)
Value$15.9M$467.0K$10.8M−$4.60M (−29.8%)

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (4)

Institutions that held Curis Inc at the end of Q3 2024 but not at the end of Q2 2024.

Institutions new to CRIS in Q3 2024
InstitutionSharesValue% of portfolio
BlackRock, Inc.68,242$367.8K0.00%
Millennium Management LLC13,270$71.5K0.00%
LPL Financial LLC10,162$54.8K0.00%
Danske Bank A/S2$110.00%

Sold out (5)

Institutions that held Curis Inc at the end of Q2 2024 and filed for Q3 2024 without it.

Institutions that sold out of CRIS in Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
Point72 Asset Management, L.P.108,356$747.7K
LMR Partners LLP10,102$69.7K
Comerica Bank50$345
FMR LLC5$35
Qube Research & Technologies Ltd2$14

Not filed for Q3 2024 yet (1)

Institutions that held Curis Inc at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding CRIS in Q2 2024 that haven't filed for Q3 2024
InstitutionShares, Q2 2024Value, Q2 2024
BlackRock Inc.67,684$467.0K